$CNMD
CONMED Corp

2014 Q2 Form 10-Q Financial Statement

#000081695614000009 Filed on July 25, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $188.2M $193.0M
YoY Change -2.51% 1.74%
Cost Of Revenue $87.12M $90.08M
YoY Change -3.28% 0.13%
Gross Profit $101.0M $102.9M
YoY Change -1.83% 3.19%
Gross Profit Margin 53.7% 53.33%
Selling, General & Admin $78.23M $77.17M
YoY Change 1.37% 4.7%
% of Gross Profit 77.44% 74.99%
Research & Development $6.854M $6.591M
YoY Change 3.99% -8.36%
% of Gross Profit 6.78% 6.4%
Depreciation & Amortization $11.40M $12.10M
YoY Change -5.79% 7.08%
% of Gross Profit 11.28% 11.76%
Operating Expenses $85.09M $87.26M
YoY Change -2.49% 5.55%
Operating Profit $15.94M $15.65M
YoY Change 1.84% -8.24%
Interest Expense $1.571M $1.383M
YoY Change 13.59% -10.83%
% of Operating Profit 9.86% 8.84%
Other Income/Expense, Net
YoY Change
Pretax Income $14.37M $14.27M
YoY Change 0.7% -7.98%
Income Tax $4.114M $4.736M
% Of Pretax Income 28.63% 33.19%
Net Earnings $10.26M $9.533M
YoY Change 7.57% -7.41%
Net Earnings / Revenue 5.45% 4.94%
Basic Earnings Per Share $0.38 $0.35
Diluted Earnings Per Share $0.37 $0.34
COMMON SHARES
Basic Shares Outstanding 27.26M shares 27.59M shares
Diluted Shares Outstanding 27.75M shares 27.98M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.40M $38.10M
YoY Change 58.53% 135.19%
Cash & Equivalents $60.41M $38.12M
Short-Term Investments
Other Short-Term Assets $27.90M $28.40M
YoY Change -1.76% 9.65%
Inventory $157.0M $148.7M
Prepaid Expenses
Receivables $135.1M $140.6M
Other Receivables $4.900M $2.800M
Total Short-Term Assets $385.3M $358.6M
YoY Change 7.45% 6.27%
LONG-TERM ASSETS
Property, Plant & Equipment $137.8M $137.6M
YoY Change 0.11% -2.29%
Goodwill $248.4M $249.2M
YoY Change -0.29% 6.1%
Intangibles $312.9M $186.8M
YoY Change 67.48% -2.56%
Long-Term Investments
YoY Change
Other Assets $12.90M $150.8M
YoY Change -91.45% -3.58%
Total Long-Term Assets $712.0M $724.4M
YoY Change -1.71% 0.09%
TOTAL ASSETS
Total Short-Term Assets $385.3M $358.6M
Total Long-Term Assets $712.0M $724.4M
Total Assets $1.097B $1.083B
YoY Change 1.32% 2.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.76M $27.22M
YoY Change -1.7% -6.31%
Accrued Expenses $28.20M $25.90M
YoY Change 8.88% 6.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.187M $1.093M
YoY Change 8.6% -95.15%
Total Short-Term Liabilities $104.6M $99.16M
YoY Change 5.52% -26.69%
LONG-TERM LIABILITIES
Long-Term Debt $244.8M $233.0M
YoY Change 5.07% 60.22%
Other Long-Term Liabilities $28.39M $60.55M
YoY Change -53.12% -30.99%
Total Long-Term Liabilities $273.2M $293.6M
YoY Change -6.93% 25.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $104.6M $99.16M
Total Long-Term Liabilities $273.2M $293.6M
Total Liabilities $495.2M $498.4M
YoY Change -0.64% 6.52%
SHAREHOLDERS EQUITY
Retained Earnings $403.8M $389.6M
YoY Change 3.65% 6.39%
Common Stock $313.0K $313.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $111.1M $99.21M
YoY Change 11.98% 49.12%
Treasury Stock Shares
Shareholders Equity $602.2M $584.7M
YoY Change
Total Liabilities & Shareholders Equity $1.097B $1.083B
YoY Change 1.32% 2.05%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $10.26M $9.533M
YoY Change 7.57% -7.41%
Depreciation, Depletion And Amortization $11.40M $12.10M
YoY Change -5.79% 7.08%
Cash From Operating Activities $7.900M $17.70M
YoY Change -55.37% -31.13%
INVESTING ACTIVITIES
Capital Expenditures -$4.500M -$4.100M
YoY Change 9.76% -21.15%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$4.500M -$4.100M
YoY Change 9.76% -21.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K -6.800M
YoY Change -98.53% -70.31%
NET CHANGE
Cash From Operating Activities 7.900M 17.70M
Cash From Investing Activities -4.500M -4.100M
Cash From Financing Activities -100.0K -6.800M
Net Change In Cash 3.300M 6.800M
YoY Change -51.47% -383.33%
FREE CASH FLOW
Cash From Operating Activities $7.900M $17.70M
Capital Expenditures -$4.500M -$4.100M
Free Cash Flow $12.40M $21.80M
YoY Change -43.12% -29.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
26760000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27448000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
140426000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135081000 USD
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2362000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2116000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17572000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15279000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P27Y
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
326436000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
324366000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14648000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
12831000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7009000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3278000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3521000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6490000 USD
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2014Q2 us-gaap Assets
Assets
1097324000 USD
CY2013Q4 us-gaap Assets
Assets
1090508000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
385326000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
372132000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54443000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60414000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38123000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23720000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14403000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5971000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2014Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7380000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21174000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11597000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18754000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18754000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21174000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7380000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11597000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87122000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
174409000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
166481000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90077000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3837000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5038000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
13202000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
13101000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1147000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1183000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
113199000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
117331000 USD
CY2013Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-732000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-855000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-1463000 USD
CY2014Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-427000 USD
CY2014Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1496000 USD
CY2013Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1302000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2604000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2992000 USD
CY2014Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
877000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1753000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1571000 USD
CY2014Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-120000 USD
CY2013Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
785000 USD
CY2013Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
284000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
568000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-239000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
145000 USD
CY2014Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
72000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
138000 USD
CY2013Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
69000 USD
us-gaap Depreciation
Depreciation
9168000 USD
us-gaap Depreciation
Depreciation
9473000 USD
CY2013Q4 us-gaap Derivative Assets
DerivativeAssets
1027000 USD
CY2014Q2 us-gaap Derivative Assets
DerivativeAssets
1222000 USD
CY2014Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-1936000 USD
CY2013Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-2223000 USD
CY2013Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
3250000 USD
CY2014Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3158000 USD
CY2013Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4123000 USD
CY2014Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5468000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1365000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
963000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.375
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.298
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28199000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33426000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112563000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
106073000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12651000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13019000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12450000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12450000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
12507000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12519000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1600000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
200000 USD
CY2014Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
500000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-200000 USD
CY2013Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q2 us-gaap Goodwill
Goodwill
248427000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-263000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
248428000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-1000 USD
us-gaap Gross Profit
GrossProfit
205598000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
102916000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
101028000 USD
us-gaap Gross Profit
GrossProfit
203610000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14369000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
28510000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14269000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
30216000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4736000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8485000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4114000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11335000 USD
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4917000 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3805000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1353000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2207000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2689000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5584000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1013000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1171000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5260000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7393000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19163000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1581000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-3129000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-6032000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-834000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3714000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-9729000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2256000 USD
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
425457000 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
425513000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
319440000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
312894000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
1383000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
1571000 USD
us-gaap Interest Expense
InterestExpense
2749000 USD
us-gaap Interest Expense
InterestExpense
3032000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1725000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
89446000 USD
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
94047000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
143211000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
157006000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
39029000 USD
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
47061000 USD
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15898000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14736000 USD
CY2013Q2 us-gaap Legal Fees
LegalFees
527000 USD
CY2014Q2 us-gaap Legal Fees
LegalFees
1410000 USD
us-gaap Legal Fees
LegalFees
736000 USD
us-gaap Legal Fees
LegalFees
3304000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
484189000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
495170000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1097324000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1090508000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
104624000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
111265000 USD
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1187000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1140000 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
244830000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
214435000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.&#160;&#160;The Company&#8217;s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology and gastroenterology.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11264000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
815000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8201000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8641000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24913000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23154000 USD
us-gaap Net Income Loss
NetIncomeLoss
20025000 USD
us-gaap Net Income Loss
NetIncomeLoss
18881000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
10255000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
9533000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2506000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
558000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-528000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
379000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
197000 USD
us-gaap Operating Expenses
OperatingExpenses
170362000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
85088000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
87264000 USD
us-gaap Operating Expenses
OperatingExpenses
174076000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15940000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
33248000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31522000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15652000 USD
CY2013Q4 us-gaap Other Assets
OtherAssets
10340000 USD
CY2014Q2 us-gaap Other Assets
OtherAssets
11772000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1557000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1601000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4699000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2993000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-269000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-922000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-539000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-461000 USD
CY2013Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2093000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3906000 USD
CY2014Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2839000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6036000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47135000 USD
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
46116000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45290000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28385000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
44729000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16862000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1815000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1736000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
31000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10366000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
953000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7090000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1857000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1814000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2422000 USD
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2343000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3272000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3636000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2178000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1885000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14807000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17045000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
73000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10987000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8445000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8641000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8201000 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Professional Fees
ProfessionalFees
0 USD
CY2014Q2 us-gaap Professional Fees
ProfessionalFees
935000 USD
us-gaap Professional Fees
ProfessionalFees
0 USD
us-gaap Professional Fees
ProfessionalFees
1525000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137758000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138985000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
227000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
515000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6854000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12285000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13764000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6591000 USD
us-gaap Restructuring Charges
RestructuringCharges
1016000 USD
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
2259000 USD
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
3128000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
395889000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
403848000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
188150000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
370091000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
380007000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
192993000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147844000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77174000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74026000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
154899000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2496000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2518000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
606319000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
602154000 USD
CY2014Q2 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3958389 shares
CY2013Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3718332 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
98747000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
111094000 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
496000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
500000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
398000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
392000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28258000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27983000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27803000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27257000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27860000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27303000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27591000 shares
CY2013Q2 cnmd Excise Tax Medical
ExciseTaxMedical
1406000 USD
cnmd Excise Tax Medical
ExciseTaxMedical
2986000 USD
CY2014Q2 cnmd Excise Tax Medical
ExciseTaxMedical
1369000 USD
cnmd Excise Tax Medical
ExciseTaxMedical
2718000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Amount
JointDevelopmentAndDistributionAgreementConditionalPaymentAmount
84000000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Period
JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod
P4Y
CY2012Q1 cnmd Joint Development And Distribution Agreement Up Front Payment
JointDevelopmentAndDistributionAgreementUpFrontPayment
63000000 USD
CY2014Q2 cnmd Joint Developmentand Distribution Agreement Conditional Payment Amount Accrued
JointDevelopmentandDistributionAgreementConditionalPaymentAmountAccrued
33300000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
34000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
16667000 USD
CY2014Q2 cnmd Product Liability Contingency Insurance Aggregate Annual Amount
ProductLiabilityContingencyInsuranceAggregateAnnualAmount
25000000 USD
CY2014Q2 cnmd Product Liability Contingency Insurance Amount Per Incident
ProductLiabilityContingencyInsuranceAmountPerIncident
25000000 USD
cnmd Product Warranty Accrual Term
ProductWarrantyAccrualTerm
P1Y
CY2013Q2 cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
1566000 USD
cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
1207000 USD
CY2014Q2 cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
494000 USD
cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
3170000 USD
cnmd Restructuringand Related Activities Completion Period
RestructuringandRelatedActivitiesCompletionPeriod
P18M
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000816956
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27344609 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CONMED CORP

Files In Submission

Name View Source Status
0000816956-14-000009-index-headers.html Edgar Link pending
0000816956-14-000009-index.html Edgar Link pending
0000816956-14-000009.txt Edgar Link pending
0000816956-14-000009-xbrl.zip Edgar Link pending
cnmd-20140630.xml Edgar Link completed
cnmd-20140630.xsd Edgar Link pending
cnmd-20140630_cal.xml Edgar Link unprocessable
cnmd-20140630_def.xml Edgar Link unprocessable
cnmd-20140630_lab.xml Edgar Link unprocessable
cnmd-20140630_pre.xml Edgar Link unprocessable
cnmd6301410-q.htm Edgar Link pending
cnmd63014ex311.htm Edgar Link pending
cnmd63014ex312.htm Edgar Link pending
cnmd63014ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending